CN1813738A - 母猪产后清宫、护宫外用药剂 - Google Patents

母猪产后清宫、护宫外用药剂 Download PDF

Info

Publication number
CN1813738A
CN1813738A CN 200510032545 CN200510032545A CN1813738A CN 1813738 A CN1813738 A CN 1813738A CN 200510032545 CN200510032545 CN 200510032545 CN 200510032545 A CN200510032545 A CN 200510032545A CN 1813738 A CN1813738 A CN 1813738A
Authority
CN
China
Prior art keywords
sow
puerperal
cleaning
uterus
external
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510032545
Other languages
English (en)
Inventor
刘满秋
曾德年
刘超良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200510032545 priority Critical patent/CN1813738A/zh
Publication of CN1813738A publication Critical patent/CN1813738A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

母猪产后清宫、护宫外用药剂,其特征在于它是组成成分及重量配比为:氯化钠10-13%、氯化钾5-7%、碳酸氢钠8-10%、葡萄糖70-76%、马来酸麦角新碱0.0015-0.0025%、甲硝唑0.6-0.8%的克溶性粉剂。本发明的优点是经济实用,使用方便,有效地防治母猪产后易引发的子宫内膜炎,对提高繁殖性能,预防母猪繁殖疾病有显著效果。

Description

母猪产后清宫、护宫外用药剂
技术领域:本发明涉及一种母猪产后用药,特别是一种母猪产后清宫、护宫外用药剂。
背景技术:
母猪产仔后由于母猪产前阴部清洗不干净,产舍及接产医械消毒不严等诸多原因常易引起母猪子宫内膜炎。母猪子宫内膜炎是导致母猪繁殖障碍的主要疾病之一,发生率达5-30%,因子宫内膜炎引起的母猪不发情或虽发情而屡配不孕约占母猪生殖系统疾病的70%左右。母猪患子宫内膜炎后,轻者发情不正常,受胎率低;重者长时间不发情,或者屡配不孕,或者假孕空胎,导致母猪生产率低,淘汰率下降,造成严重经济损失。
现在市场缺乏一种实用、经济而有效的防治母猪产后患子宫内膜炎的外用药物。
发明内容:
本发明的目的在于提供一种经济实用,有效的防治母猪产后易患子宫内膜炎的外用药剂。
本发明的技术解决方案是母猪产后清宫、护宫外用药剂,它是组成成分及重量配比为:氯化钠10-13%、氯化钾5-7%、碳酸氢钠8-10%、葡萄糖70-76%、马来酸麦角新碱0.0015-0.0025%、甲硝唑0.6-0.8%的克溶性粉剂。其组分最佳重量配比为:氯化钠12.3%、氯化钾5.5%、碳酸氢钠8.9%、葡萄糖72.63%、马来酸麦角新碱0.002%、甲硝唑0.668%。
具体实施方式:
本发明结合具体实施例进一步说明如下:
一种母猪产后清宫、护宫外用药剂,制取1000kg该药剂:取氯化钠123kg、氯化钾55kg、碳酸氢钠89kg、葡萄糖726.31kg、马来酸麦角新碱0.02kg、甲硝唑6.67kg,充分混合均匀即成粉剂,按每袋150g分袋包装。
使用时,每袋药剂溶于5kg温开水重搅匀,冲洗母猪子宫。
本发明母猪产后清宫、护宫外用药剂的药理作用是:
1、兴奋母猪子宫体,促进母猪产后子宫内恶露的排出。
2、调节母猪子宫生理免疫机能,促进子宫复原,有利于母猪产后生殖机能的迅速恢复。
3、提高母猪健康水平,促进母猪断奶后发情,提高受胎率。
本发明的优点是经济实用,使用方便,有效地防治母猪产后易引发的子宫内膜炎,对提高母猪繁殖性能,预防母猪繁殖疾病有显著效果。

Claims (2)

1、母猪产后清宫、护宫外用药剂,其特征在于它是组成成分及重量配比为:氯化钠10-13%、氯化钾5-7%、碳酸氢钠8-10%、葡萄糖70-76%、马来酸麦角新碱0.0015-0.0025%、甲硝唑0.6-0.8%的可溶性粉剂。
2、根据权利要求1所述的母猪产后清宫、护宫外用药剂,其特征在于其组分重量配比为:氯化钠12.3%、氯化钾5.5%、碳酸氢钠8.9%、葡萄糖72.63%、马来酸麦角新碱0.002%、甲硝唑0.668%。
CN 200510032545 2005-12-14 2005-12-14 母猪产后清宫、护宫外用药剂 Pending CN1813738A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510032545 CN1813738A (zh) 2005-12-14 2005-12-14 母猪产后清宫、护宫外用药剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510032545 CN1813738A (zh) 2005-12-14 2005-12-14 母猪产后清宫、护宫外用药剂

Publications (1)

Publication Number Publication Date
CN1813738A true CN1813738A (zh) 2006-08-09

Family

ID=36906172

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510032545 Pending CN1813738A (zh) 2005-12-14 2005-12-14 母猪产后清宫、护宫外用药剂

Country Status (1)

Country Link
CN (1) CN1813738A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000145A (zh) * 2010-12-16 2011-04-06 南京日升昌生物技术有限公司 防治母畜子宫内膜炎的中西药复方灌注液及其制备方法
CN105770721A (zh) * 2014-12-22 2016-07-20 天津嘉创生物科技有限公司 防治母猪产后热的中药制剂及其制备方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102000145A (zh) * 2010-12-16 2011-04-06 南京日升昌生物技术有限公司 防治母畜子宫内膜炎的中西药复方灌注液及其制备方法
CN102000145B (zh) * 2010-12-16 2011-11-23 南京日升昌生物技术有限公司 防治母畜子宫内膜炎的中西药复方灌注液及其制备方法
CN105770721A (zh) * 2014-12-22 2016-07-20 天津嘉创生物科技有限公司 防治母猪产后热的中药制剂及其制备方法

Similar Documents

Publication Publication Date Title
US20210275528A1 (en) Methods of treating heavy menstrual bleeding
RU2568839C2 (ru) Способ и композиция для синхронизации времени осеменения
CN103313715A (zh) 基底子宫内膜异位相关疼痛的治疗
CN102088954A (zh) 用于避孕的子宫内输送系统
SG187529A1 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
ES2808409T3 (es) Método para sincronizar el tiempo de inseminación en cerdas primerizas
JP2010539153A5 (zh)
CN1813738A (zh) 母猪产后清宫、护宫外用药剂
CA2864073A1 (en) Method for treating gynecological diseases
Nie et al. Use of a glass ball to suppress behavioral estrus in mares
ES2293215T3 (es) Uso de una combinacion de un inhibidor de aromatasa, un progestageno y un estrogeno para el tratamiento de endometriosis.
RANNEY Endometriosis II Emergency Operations Due to Hemoperitoneum
RU2013112954A (ru) Способ предупреждения преждевременных родов
CN102335120A (zh) 一种用于治疗母猪子宫炎、阴道炎的聚维酮碘泡腾栓剂
CN104394870A (zh) 选择性孕酮受体调节剂和非甾体抗炎药物的组合
Hinrichs et al. Birth of a foal after oocyte transfer to a nonovulating, hormone-treated recipient mare
CN102397587A (zh) 一种宫腔防粘连材料及其制备工艺和用途
Hernandez-Fonseca et al. Embryotoxic effects adjacent and opposite to the early regressing bovine corpus luteum
Runcan et al. Complications associated with the use of intrauterine glass marbles to suppress estrus in a Standardbred mare
CN104546870B (zh) 一种避孕药
CN104540497A (zh) 用于制备治疗子宫内膜异位的含低剂量米非司酮的速释型口服片剂的制剂、如此得到的片剂及其制备方法
Thuemmel et al. Effect of progesterone supplementation in repeat-breeder cattle on conception and plasma progesterone
KR20150085512A (ko) 필요시 피임을 위한 레보노르게스트렐 및 cox 억제제 함유 제약 조성물의 용도 및 적용 요법
Žilaitis et al. The prevalence of clinical metritis and fertility indices in cows treated with low-intensity laser irradiation and antibiotics in the postpartum period.
CN101259119B (zh) 一种丝氨酸蛋白酶抑制剂及其衍生物在生育调节中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication